Collaboration Leading to Addiction Treatment and Recovery from Other Stresses (CLARO) is a five-year project that tests whether delivering care using a collaborative model helps patients with both opioid use disorders and mental health disorders.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Buprenorphine access
Timeframe: Assessed at 6 months after study entry.
Buprenorphine continuity of care
Timeframe: Assessed at 6 months after study entry.
Major Depressive Disorder (MDD) symptom severity
Timeframe: Assessed at 6 months after study entry.
Post-traumatic Stress Disorder (PTSD) symptom severity
Timeframe: Assessed at 6 months after study entry.